InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Allen Andrew R, Chairman & CEO. Director active across 3 companies, notably Epizyme, Inc.. Aggregated, 6 filings have been logged. The latest transaction was disclosed on 1 July 2022 — Disposition. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€86,6131,650 shares@ €52.4925100.0% of flow
Common Stock
SEC:0001209191-22-040258:0·
070,000 shares0
Common Stock
SEC:0001567619-22-008708:0·
048,200 shares0
Common Stock
SEC:0001567619-21-020853·
048,200 shares0
Common Stock
SEC:0001567619-21-020853:0·
08,060 shares0
Common Stock, par value $0.0001
SEC:0000899243-21-023872·
08,060 shares0
Common Stock, par value $0.0001
SEC:0000899243-21-023872:0·
6 of 6 declarations
About Allen Andrew R
Allen Andrew R is the President and CEO of Epizyme, Inc., Gritstone bio, Inc., and Sierra Oncology, Inc. He leads the operations and strategy of these companies, ensuring their growth and success. His leadership and vision are essential for achieving the objectives of each company. Andrew is committed to promoting innovation and excellence in the biopharmaceutical sector.
